How do gastric (stomach) and duodenal ulcers influence the management of iron deficiency anemia?

How Gastric and Duodenal Ulcers Affect Treatment of Iron Deficiency Anemia

Peptic ulcers (gastric and duodenal) are among the most common bleeding sources causing iron deficiency anemia and fundamentally alter management by requiring both ulcer-specific treatment and addressing the underlying H. pylori infection, which directly impairs iron absorption and hemoglobin recovery.

Primary Impact on Treatment Strategy

Ulcers as Blood Loss Sources

Peptic ulceration represents a critical finding in the evaluation of iron deficiency anemia. In patients with unexplained iron deficiency anemia undergoing endoscopic evaluation, peptic ulcers (duodenal, gastric, or anastomotic) are identified in approximately 19-29% of cases 1, 2. These ulcers cause chronic occult blood loss that perpetuates iron deficiency despite supplementation.

The H. pylori Connection

The presence of peptic ulcer disease mandates testing and treatment for H. pylori infection, which has dual significance:

• H. pylori testing and treatment is conditionally recommended by AGA guidelines after negative bidirectional endoscopy in iron deficiency anemia patients 3
• H. pylori causes hypochlorhydria and atrophic gastritis, which directly impair iron absorption from the duodenum
• Treatment of H. pylori with concurrent iron replacement produces significantly better outcomes than iron alone: mean hemoglobin improvement of 2.2 g/dL greater (95% CI, 1.3-3 g/dL) and ferritin improvement of 23.2 ng/mL greater (95% CI, 12.2-34.3 ng/mL) 3

Treatment Algorithm When Ulcers Are Identified

Step 1: Ulcer-Specific Management

• Initiate high-dose proton pump inhibitor therapy (standard ulcer healing regimen)
• Test for H. pylori via noninvasive methods (urea breath test, stool antigen, or serology) 3
• If H. pylori positive, complete eradication therapy with appropriate antibiotic regimen
• Discontinue NSAIDs if implicated, as they are frequently associated with ulcers in anemic patients 4

Step 2: Iron Repletion Strategy

• Begin oral iron supplementation concurrently with ulcer treatment 5
• Use ferrous salts (sulfate, fumarate, or gluconate) at 100-200 mg elemental iron daily 5
• Take on empty stomach when tolerated, or with meals if GI side effects occur
• Consider adding 500 mg vitamin C to enhance absorption 5

Step 3: Monitoring and Escalation

• Reassess hemoglobin and ferritin after 3 months of oral therapy
• If inadequate response to oral iron despite ulcer healing and H. pylori eradication, escalate to intravenous iron 5
• Verify ulcer healing endoscopically if anemia persists despite treatment

Critical Nuances and Pitfalls

The Acid Suppression Paradox

A common pitfall: while proton pump inhibitors are essential for ulcer healing, they simultaneously reduce iron absorption by decreasing gastric acidity. This creates a therapeutic tension where:

• Ulcer healing requires acid suppression
• Iron absorption is optimized by acidic environment
• Resolution: Prioritize ulcer healing first, then consider IV iron if oral supplementation fails 5

Oral Iron Can Cause Ulcers

Rarely documented but important: prolonged oral iron therapy itself can cause gastric ulceration 6. If a patient develops new or worsening upper GI symptoms on oral iron, consider:

• Switching to alternate-day dosing (improves tolerance without reducing efficacy)
• Transitioning to IV iron formulations
• Repeat endoscopy if symptoms persist

Distinguishing Ulcer Types Matters

• Anastomotic ulcers (post-bariatric surgery) require different management: these patients should receive IV iron preferentially due to disrupted duodenal absorption 5
• Gastric ulcers require biopsy to exclude malignancy (gastric cancer found in 2-10% of anemic patients) 1, 2

When Ulcers Are NOT Found

If bidirectional endoscopy is negative but iron deficiency persists:

• Noninvasive H. pylori testing is still recommended because infection can cause iron deficiency through atrophic gastritis alone, without visible ulceration 3
• Consider small bowel evaluation only if red flags present (weight loss, abdominal pain, elevated inflammatory markers) 7
• Trial of iron supplementation is appropriate before pursuing capsule endoscopy 3

Quality of Life and Mortality Considerations

The presence of peptic ulcers elevates management urgency because:

• Untreated H. pylori increases gastric cancer risk (WHO class I carcinogen) 3
• Ongoing blood loss from ulcers prevents anemia resolution, perpetuating fatigue and reduced functional capacity
• Treating H. pylori provides benefits beyond iron repletion: decreased gastric cancer incidence and prevention of ulcer recurrence 3

Bottom line: When peptic ulcers are identified in iron deficiency anemia, implement triple therapy—ulcer healing with PPIs, H. pylori eradication if positive, and iron supplementation—with readiness to escalate to IV iron if oral therapy fails after 3 months.